Protective effect of teriparatide against vancomycin-induced cytotoxicity in osteoblasts.

[1]  K. Tateda,et al.  Does Vitamin D3 Prevent the Inhibitory Effect of Vancomycin on Osteoblasts? , 2019, Clinical orthopaedics and related research.

[2]  A. Rosinski,et al.  Selection pressures of vancomycin powder use in spine surgery: a meta-analysis. , 2019, The spine journal : official journal of the North American Spine Society.

[3]  Marc N. Wein,et al.  Regulation of Bone Remodeling by Parathyroid Hormone. , 2018, Cold Spring Harbor perspectives in medicine.

[4]  Yin Ding,et al.  ClC-3 chloride channel mediates the role of parathyroid hormone [1-34] on osteogenic differentiation of osteoblasts , 2017, PloS one.

[5]  Yi Wang,et al.  Dose-dependence of PTH-related peptide-1 on the osteogenic induction of MC3T3-E1 cells in vitro , 2017, Medicine.

[6]  J. Thambiah,et al.  Is Intraoperative Local Vancomycin Powder the Answer to Surgical Site Infections in Spine Surgery? , 2017, Spine.

[7]  Motohiro Kato,et al.  The Optimal Duration of PTH(1-34) Infusion Is One Hour per Day to Increase Bone Mass in Rats. , 2016, Biological & pharmaceutical bulletin.

[8]  D. Nebel,et al.  1α,25-dihydroxyvitamin D3 promotes osteogenic activity and downregulates proinflammatory cytokine expression in human periodontal ligament cells. , 2015, Journal of periodontal research.

[9]  D. Cadotte,et al.  Complications from the use of intrawound vancomycin in lumbar spinal surgery: a systematic review. , 2015, Neurosurgical focus.

[10]  M. Ogon,et al.  Does intrawound application of vancomycin influence bone healing in spinal surgery? , 2015, European Spine Journal.

[11]  S. Lam,et al.  The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence. , 2015, World neurosurgery.

[12]  R. G. Richards,et al.  A phenotypic comparison of osteoblast cell lines versus human primary osteoblasts for biomaterials testing. , 2014, Journal of biomedical materials research. Part A.

[13]  Srinivas K. Prasad,et al.  Intraoperative Vancomycin Use in Spinal Surgery: Single Institution Experience and Microbial Trends , 2014, Spine.

[14]  W. Shaffer,et al.  An evidence-based clinical guideline for antibiotic prophylaxis in spine surgery. , 2013, The spine journal : official journal of the North American Spine Society.

[15]  R. Strom,et al.  Decreased Risk of Wound Infection After Posterior Cervical Fusion With Routine Local Application of Vancomycin Powder , 2013, Spine.

[16]  R. G. Richards,et al.  In search of an osteoblast cell model for in vitro research. , 2012, European cells & materials.

[17]  T. Sone,et al.  Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. , 2012, The Journal of clinical endocrinology and metabolism.

[18]  R. Molinari,et al.  Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period , 2012, European Spine Journal.

[19]  T. Sone,et al.  A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study. , 2011, Bone.

[20]  E. Schwarz,et al.  Teriparatide (1‐34 human PTH) regulation of osterix during fracture repair , 2008, Journal of cellular biochemistry.

[21]  P. Eysel,et al.  Influence on Mitochondria and Cytotoxicity of Different Antibiotics Administered in High Concentrations on Primary Human Osteoblasts and Cell Lines , 2006, Antimicrobial Agents and Chemotherapy.

[22]  R. Franceschi,et al.  Role of Matrix Gla Protein in Parathyroid Hormone Inhibition of Osteoblast Mineralization , 2006, Cells Tissues Organs.

[23]  L. Qin,et al.  Parathyroid hormone: a double-edged sword for bone metabolism , 2004, Trends in Endocrinology & Metabolism.

[24]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[25]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[26]  P. Roberson,et al.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. , 1999, The Journal of clinical investigation.

[27]  A. Yamaguchi,et al.  Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. , 1997, The Journal of clinical investigation.

[28]  L. Dahners,et al.  Effect of Cefazolin and Vancomycin on Osteoblasts In Vitro , 1996, Clinical orthopaedics and related research.

[29]  P. McSheehy,et al.  Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. , 1986, Endocrinology.

[30]  L. Klenerman,et al.  ANABOLIC EFFECT OF LOW DOSES OF A FRAGMENT OF HUMAN PARATHYROID HORMONE ON THE SKELETON IN POSTMENOPAUSAL OSTEOPOROSIS , 1976, The Lancet.